Search
for
Sort by
Research 91–120 of 1000+
- Bubble-Based Drug Delivery Systems: Next-Generation Diagnosis to Therapy
- Induced pluripotent stem cells: Generation methods and a new perspective in COVID-19 research
- Diseases of the Canine Prostate Gland
- The Potential of Hair Matrix for Biomarker Analysis in Schizophrenia
- In vivo expression of VCAM1 precedes nephron loss following kidney tubular necrosis
- Revolutionizing Radiotoxicity Management with Mesenchymal Stem Cells and Their Derivatives: A Focus on Radiation-Induced Cystitis
- Local heroes or villains: tissue-resident memory T cells in human health and disease
- Beta-caryophyllene enhances wound healing through multiple routes
- Extracellular vesicles from adipose-derived stem cells ameliorate ultraviolet B-induced skin photoaging by attenuating reactive oxygen species production and inflammation
- Finasteride Enhances the Generation of Human Myeloid-Derived Suppressor Cells by Up-Regulating the COX2/PGE2 Pathway
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study
- Chromatographic methods for determination of finasteride and tamsulosin hydrochloride and in presence of finasteride degradation product
- METHOD DEVELOPMENT AND VALIDATION OF UV-SPECTROPHOTOMETRIC ESTIMATION OF FINASTERIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- New Drugs: Dutasteride
- Are PSA adjustments necessary for prostate cancer screening in men taking finasteride for hair loss?
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Development of a Doxazosin and Finasteride Transdermal System for Combination Therapy of Benign Prostatic Hyperplasia
- Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- GC-MS Fatty Acid Profile and In silico Studies of Telfairia occidentalis Hook f. (Fluted Pumpkin) and Sphenostylis stenocarpa (African Yam bean) Seeds Oil on Human 5 Alpha Reductase II
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Current treatment of BPH
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Topically Applied Minoxidil in Baldness
- Biochemical and Histopathological evaluation of prostatic tissue under effect of Pterostilbene in benign prostatic hyperplasia rat model
- Aldesleukin
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction